Anhydroicaritin suppresses tumor progression via the PI3K/AKT signaling pathway in hepatocellular carcinoma

Houhong Wang; Wenli Chen; Yayun Cui; Huihui Gong; Amao Tang

doi:doi:10.18632/aging.204948

← Back

Research Paper Volume 15, Issue 15 pp 7831—7843

Anhydroicaritin suppresses tumor progression via the PI3K/AKT signaling pathway in hepatocellular carcinoma

Figure 8. AHI has potential anti-liver cancer properties. (A) Colony formation of HepG2 after treatment with different concentrations of AHI. (B) Sphere formation of HepG2 after treatment with different concentrations of AHI. (C) Effects of AHI on the migration of HCC cell. (D) Effects of AHI on the invasion of HCC cell.